NDC 10135-735 – Pyrazinamide
Pyrazinamide 500 mg/1 · Tablet · Oral
Product NDC10135-735
Product details
- Brand name
- Pyrazinamide
- Generic name
- Pyrazinamide tablet
- Labeler
- MARLEX PHARMACEUTICALS, INC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA080157
- Marketed since
- March 1, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Antimycobacterial
Active ingredients
- Pyrazinamide 500 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 10135-735-01 | 100 TABLET in 1 BOTTLE (10135-735-01) | Mar 1, 2022 |
| 10135-735-60 | 60 TABLET in 1 BOTTLE (10135-735-60) | Mar 1, 2022 |
| 10135-735-90 | 90 TABLET in 1 BOTTLE (10135-735-90) | Mar 1, 2022 |